Jonas, Jost B. http://orcid.org/0000-0003-2972-5227
Dong, Li
Da Chen, Shi
Neumaier, Michael
Findeisen, Peter
Panda-Jonas, Songhomitra
Jonas, Rahul A.
Funding for this research was provided by:
Medizinische Fakultät Mannheim der Universität Heidelberg
Article History
Received: 7 October 2020
Revised: 12 March 2021
Accepted: 11 April 2021
First Online: 29 May 2021
Declarations
:
: The Medical Ethics Committee II of the Medical Faculty Mannheim of the Ruprecht-Karls University Heidelberg approved the study protocol and had waived the necessity to obtain the written consent of the individual patients.
: Jost B. Jonas, Songhomitra Panda-Jonas, Rahul A. Jonas: European patent application: 16 720 043.5 and Patent application US 2019 0085065 A1:„Agents for use in the therapeutic or prophylactic treatment of myopia or hyperopia); Patent application: Agents for use in the therapeutic or prophylactic treatment of retinal pigment epithelium associated diseases.